Musallam, Khaled M.
Cappellini, Maria Domenica
Daar, Shahina
Taher, Ali T.
Article History
Received: 19 November 2020
Accepted: 30 November 2020
First Online: 20 January 2021
Compliance with ethical standards
:
: K.M.M. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Agios Pharmaceuticals, CRISPR Therapeutics, and Vifor Pharma. M.D.C. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma and Ionis Pharmaceuticals, and received research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics and CRISPR Therapeutics. S.D. has nothing to disclose. A.T.T. has been or is a consultant for Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma, Silence Therapeutics and Ionis Pharmaceuticals, and received research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist Therapeutics and Agios Pharmaceuticals.
: Data were collected as part of now completed clinical studies, which were approved by the Institutional Review Board at all institutions. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients had signed an informed consent form for participating in the original studies in accordance with the Declaration of Helsinki.